View : 279 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author이정연-
dc.contributor.author김선아-
dc.contributor.author강지은-
dc.date.accessioned2020-02-07T16:30:10Z-
dc.date.available2020-02-07T16:30:10Z-
dc.date.issued2020-
dc.identifier.issn2045-2322-
dc.identifier.otherOAK-26420-
dc.identifier.urihttp://dspace.ewha.ac.kr/handle/2015.oak/253325-
dc.description.abstractThe curative effects of nanoparticle albumin-bound (nab)-paclitaxel in the first-line treatment of metastatic breast cancer (MBC) are still controversial, with even more after the removal of marketing approval of indication of bevacizumab. Five electronic databases and the related resources were searched for eligible randomized clinical trials (RCTs) without year and language restrictions to perform a meta-analysis. The studies were comparing the efficacy and safety between nab-paclitaxel chemotherapy versus solvent-based (sb)-taxanes chemotherapy such as sb-paclitaxel and docetaxel. The primary end points were overall response rate (ORR) and disease control rate (DCR). Secondary end points were progression-free survival (PFS), overall survival (OS), adverse events (AEs), and dose discontinuation rate (DDR). Five RCTs (1,554 patients) were finally identified from 1,902 studies. When compared to sb-paclitaxel, nab-paclitaxel showed significant beneficial effects in terms of ORR (OR 2.39, 95% CI 1.69–3.37, p < 0.001), DCR (OR 1.89, 95% CI 1.07–3.35, p = 0.03), and PFS (HR 0.75, 95% CI 0.62–0.90, p = 0.002). Nab-paclitaxel also showed significantly longer OS (HR 0.73, 95% CI 0.54–0.99, p = 0.04) than docetaxel. AEs and DDR were comparable between the two arms. Using nab-paclitaxel could significantly improve efficacy with comparable toxicities in the treatment of MBC. © 2020, The Author(s).-
dc.languageEnglish-
dc.publisherNature Research-
dc.titleEfficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis-
dc.typeArticle-
dc.relation.issue1-
dc.relation.volume10-
dc.relation.indexSCIE-
dc.relation.indexSCOPUS-
dc.relation.journaltitleScientific Reports-
dc.identifier.doi10.1038/s41598-019-57380-0-
dc.identifier.wosidWOS:000562812800003-
dc.identifier.scopusid2-s2.0-85077973158-
dc.author.googleLee H.-
dc.author.googlePark S.-
dc.author.googleKang J.E.-
dc.author.googleLee H.M.-
dc.author.googleKim S.A.-
dc.author.googleRhie S.J.-
dc.contributor.scopusid이정연(55581283700)-
dc.date.modifydate20210127165743-
Appears in Collections:
약학대학 > 약학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE